Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2022.669 | Photobiomodulation for enhancing cognitive efficiency in adults |
Mr. LEE Tsz Lok 李子樂 |
| 2014.544 | The Benefits of Health Qigong for Patients with Mild Cognitive Impairment (MCI): Randomized Clinical Trial | Miss LEE Tsz Mei |
| 2011.420 | Treatment Outcomes, Safety Profiles, and Subgroup Response Characteristics of TKIs Compared to Standard Chemotherapy in treating patients with chronic-phase chronic myelogenous leukaemia (CP-CML): A Retrospective Study in an HA-managed hopsital | Mr. Lee Tsz Yat |
| 2011.456 | The relationship between hope level, rumination response style and adjustment among childhood cancer patients | Dr Lee Vincent |
| 2009.405 | Myeloid Leukaemia Down Syndrome 2006 Protocol for the Treatment of Myeloid Leukaemia in Children with Down Syndrome | Dr. LEE Vincent |
| 2010.431 | Allogeneic marrow derived ex vivo expanded mesenchymal stem cell as a rescue agent for treatment of steroid resistant graft versus host disease in paediatric patients after alogeneic haematopoietic stem cell transplantation | Dr Lee Vincent |
| 2011.403 | International Consortium for Childhood Acute promyelocytic Leukemia-treatment study for patients with acute promyelocytic leukemia under 21 years of age (under 18 year for Hong Kong) | Dr. Lee Vincent |
| 2024.550 | Incidence and Predictors for Long-Term Nephrotoxicity in Childhood Cancer Survivors | Dr. LEE Vincent |
| 2019.719 | Use of archived blood samples for establishment of an assay to assess the thymic function and B-cell neogenesis |
Dr. LEE Vincent 李偉生 |
| 2015.719 | NOPHO-DBH AML 2012 Protocol Research study for treatment of children and adolescents with acute myeloid leukaemia 0-18 years |
Dr. LEE Vincent 李偉生 |
| 2017.500 | The Impact of Cancer and Treatment-related Effects on the Physical and Psychosocial Well-being and Quality of Life among Hong Kong Chinese Survivors of Childhood Osteosarcoma: An Exploratory Study |
Dr. LEE Vincent 李偉生 |
| 2013.542 | Use of Activated Donor Natural Killer Cell Infusions for Relapsed or Refractory Non-B Lineage Haematological Malignancies and Malignant Solid Tumours | Dr LEE Vincent |
| 2013.219 | High Risk Neuroblastoma Study 1.5 of SIOP-Europe (SIOPEN) | Dr. Lee Vincent |
| 2009.340 | Clinical bioequivalence study on two ampicillin formulations | Prof. Lee Vincent Hon Leung |
| 2009.339 | Clinical bioequivalence study on two amisulpride formulations | Prof. Lee Vincent Hon Leung |
| 2011.184 | Clinical Bioequivalence Study on Two Methylphenidate Formulations | Prof. Lee Vincent Hon Leung |
| 2010.598 | Clinical Bioequivalence Study on Two Gliclazide Formulations | Prof. Lee Vincent Hon Leung |
| 2014.226 | Clinical bioequivalence study on two metformin formulations | Prof. Lee Vincent Hon Leung |
| 2009.095 | Clinical Bioequivalence Study on Two Losartan Formulations | Prof. Lee Vincent Hon Leung |
| 2009.422 | Clinical bioequivalence study on two quetiapine formulations | Prof. Lee Vincent Hon Leung |
| 2009.420 | Clinical bioequivalence study on two zopiclone formulations | Prof. Lee Vincent Hon Leung |
| 2011.040 | Clinical Bioequivalence Study on Two Ursodeoxycholic Acid Formulations | Prof. Lee Vincent Hon Leung |
| 2009.419 | Clinical bioequivalence study on two famotidine formulations | Prof. Lee Vincent Hon Leung |
| 2009.462 | Clinical Bioequivalence Study on Two Perindopril formulations | Prof. Lee Vincent Hon Leung |
| 2010.118 | Clinical Bioequivalence Study on Two Metoprolol Tartrate Formulations | Prof. Lee Vincent Hon Leung |
| 2009.065 | Clinical Bioequivalence Study on Two Flecainide Formulations | Prof. Lee Vincent Hon Leung |
| 2013.345 | Clinical Bioequivalence Study on Two Crotamiton Cream Formulations | Prof. LEE Vincent Hon Leung |
| 2014.405 | Clinical bioequivalence study on two gliclazide 80 mg tablet formulations | Prof. LEE Vincent Hon Leung |
| 2009.389 | A randomized, double-masked, multicenter, laser-controlled Phase III study assessing the efficacy and safety of ranibizumab (intravitreal injections) as adjunctive and mono-therapy in patients with visual impairment due to diabetic macular edema | Dr. Lee Vincent Yau Wing |
| 2008.121 | Pars Plana Vitrectomy versus Combined pars Plana Vitrectomyscleral Buckle for Primary Repair of Inferior Rhegmatogenous Retinal Detachment: A Randomized Control Trial | Dr Lee Vincent Yau-Wing |
| 2008.390 | Prospective Comparative Study on the Safety and Efficacy of Nasal Versus Temporal Phacoemulsification | Dr Lee Vincent Yau-Wing |
| 2025.048 | Impact of theory-based interprofessional guided program using Artificial Intelligence Chatbot in diabetes management at primary health care setting of Hong Kong – A Randomised Controlled Trial | Prof. LEE Vivian |
| 2016.492 | The Impact of Beliefs towards Illness and Medications on Adherence and Clinical Outcomes in Acute Coronary Syndrome Patients | Prof LEE Vivian W.Y. |
| 2014.444 | Cost-Effectiveness Analysis of XELOX versus FOLFOX-4 regimens with or without Bevacizumab in the first line management of metastatic colorectal cancer (MCRC) in Hong Kong | Prof. Lee Vivian Wing Yan |
| 2016.495 | Identification of Low Risk Stable Cardiovascular Patients for Fast Track Medication Refill (FTMR) Services | Prof. LEE Vivian Wing Yan |
| 2013.667 | A Retrospective Cost Analysis on the Management of Atrial Fibrilltion with New Oral Anticoagulants and Warfarin in Hong Kong | Prof. Lee Vivian Wing Yan |
| 2017.288 | Clinical efficacy and cost-consequence analysis of statin management in Chinese Acute Coronary Syndrome Patients – A population-based study |
Dr. LEE Vivian Wing Yan 李詠恩 |
| 2017.246 | MAY MEASUREMENT MONTH (MMM) |
Prof. LEE Vivian Wing Yan 李詠恩 |
| 2016.273 | A Population-based Analysis to Investigate the Target LDL-C Levels to Improve Survival in Hong Kong Chinese and US Caucasian Acute Coronary Syndrome Patients: Clinical Big Data in Real World |
Prof. LEE Vivian Wing Yan 李詠恩 |
| 2011.457 | The Direct Medical Cost of the Management of Diastolic Heart Failure: a Retrospective, Cross-sectional, Stratified Cost of Illness Study in Hong Kong | Dr. Lee Vivian Wing Yan |
| 2011.458 | Drug Use Evaluation of dabigatran in Hong Kong | Dr. Lee Vivian Wing Yan |
| 2011.149 | Cost-Effectiveness of Pneumococcal Vaccination for Infants with the Pneumococcal 13-Valent Conjugate Vaccine in Hong Kong | Prof. Lee Vivian Wing Yan |
| 2013.238 | Balancing the thrombotic and bleeding risk profile of Acute Coronary Syndrome Patients - a Translational Model Analysis | Prof. LEE Vivian Wing Yan |
| 2023.044 | A theory-based interprofessional educational program to improve COVID vaccination rate among Hong Kong Chinese community-dwelling elders |
Prof. LEE Vivian Wing Yan 李詠恩 |
| 2004.366 | Multidisciplinary approach (MDA) Program to Control Hyperlipidaemia in High Risk Coronary Heart Disease Patients | Prof. Lee Vivian Wing Yan |
| 2009.131 | Clinical Impact of Elderly Outreach Program in Coronary Heart Disease | Prof. Lee Vivian Wing Yan |
| 2014.012 | Platform for Heart Failure and Atrial fibrillation Care in Elderly and Disadvantaged population | Prof. Lee Vivian Wing Yan |
| 2011.060 | The Cost of Stable Coronary Heart Disease Diagnosis and Management - A Retrospective, Non-Randomised 1-year Cost-of-Illness study in Hong Kong | Dr. Lee Vivian Wing Yan |
| 2024.155 | A self-determination theory-based interprofessional intervention to improve diabetes management in the primary health care setting of Hong Kong | Prof. LEE Vivian Wing Yan |
| 2020.317 | Economic Evaluation of Metastatic Breast Cancer After Trastuzumab-based Treatment of HER2+ Early-stage Breast Cancer in Hong Kong. |
Prof. LEE Vivian Wing Yan 李詠恩 |
Page 147 of 288.